reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalize...
2025 JCO: Precision Oncology doi: 10.1200/po-24-00450pmid: 39772831 PURPOSEPancreatic acinar cell carcinoma (PACC) is a rare and aggressive form of pancreatic cancer that originates in the acinar cells of the exocrine pancreas. In this study, we aimed to investigate the clinical and molecular ...
JCO® Oncology Practice(Impact Factor: 3.840*) - Focuses on the mechanics of practice and keeps readers current on developments, breakthroughs, and challenges in high-quality care delivery. A wide variety of perspectives are included—socioeconomics, clinical trials, health policy, ethics, health ...
today announced that detailed findings of the performance of its Galleri®multi-cancer early detection (MCED) test in prostate cancer were published inJCO Precision Oncology. The data support the clinical performance of the Galleri